CROSS SYNC uses AI for real-time patient monitoring and data-driven care, optimizing medical workflows to enhance diagnosis and treatment.
CROSS SYNC has raised $1.5M in total funding. The most recent round was Series A. The last funding was announced in October 2025.
CROSS SYNC's investors include Allm, Development Bank of Japan, IT-Farm, Konica Minolta, Toyota Tsusho.
CROSS SYNC is headquartered in Nishi, Japan.
CROSS SYNC uses AI for real-time patient monitoring and data-driven care, optimizing medical workflows to enhance diagnosis and treatment.
CROSS SYNC is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CROSS SYNC — Funding & Investors." VCBacked, October 6, 2025, https://www.vcbacked.co/company/cross-sync. Accessed August 16, 2026.
VCBacked. (2025). CROSS SYNC — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/cross-sync
{{cite web |title=CROSS SYNC — Funding & Investors |url=https://www.vcbacked.co/company/cross-sync |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated